© 2000 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease
From the Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Center on Aging at Tufts University, and the Division of Endocrinology, Metabolism, Diabetes, and Molecular Medicine (B.F.A., J.R.M., K.V.H., E.J.S.), New England Medical Center, Boston, Mass; the Physiology Department (P.S.R.), Louisiana State University Medical Center, New Orleans; the Division of Cardiology (R.L.M.), Alton Ochsner Hospital, New Orleans, La; and Pennington Biomedical Research Center (M.L.), Baton Rouge, La.
Correspondence to Bela F. Asztalos, PhD, JM-USDA/HNRC at Tufts University, Lipid Metabolism Laboratory, 711 Washington St, Boston, MA 02111. E-mail belaasztalos{at}yahoo.com
Abstract—High
density lipoproteins (HDLs) and their subspecies play a role in the
development of coronary heart disease (CHD). HDL subpopulations
were measured by 2-dimensional nondenaturing gel electrophoresis in 79
male control subjects and 76 male CHD patients to test the hypothesis
that greater differences in apolipoprotein (apo)A-I–containing HDL
subpopulations would exist between these 2 groups than for traditional
lipid levels. In CHD subjects, HDL cholesterol (HDL-C) was
lower (-14%, P<0.001), whereas total cholesterol and
the low density lipoprotein cholesterol/HDL-C ratio were
higher (9% [P<0.05] and 21%
[P<0.01], respectively) compared with control
levels. No significant differences were found for low density
lipoprotein cholesterol, triglyceride, and
apoA-I levels. In CHD subjects, there were significantly
(P<0.001) lower concentrations of the large
lipoprotein (Lp)A-I 
1 (-35%),
pre-1 (-50%),
pre-2 (-33%), and
pre-3 (-31%) subpopulations, whereas the
concentrations of the small LpA-I/A-II 3
particles were significantly (P<0.001) higher (20%).
Because 1 was decreased more than HDL-C and
plasma apoA-I concentrations in CHD subjects, the ratios of HDL-C to
1 and of apoA-I to
1 were significantly
(P<0.001) higher by 36% and 57%, respectively,
compared with control values. Subjects with low HDL-C levels (
35
mg/dL) have different distributions of apoA-I–containing HDL
subpopulations than do subjects with normal HDL-C levels (>35 mg/dL).
Therefore, we stratified participants according to HDL-C concentrations
into low and normal groups. The differences in lipid levels between
controls and HDL-C–matched cases substantially decreased; however, the
significant differences in HDL subspecies remained. Our research
findings support the concept that compared with control subjects, CHD
patients not only have HDL deficiency but also have a major
rearrangement in the HDL subpopulations with significantly lower
1 and pre-1–3
(LpA-I) and significantly higher 3
(LpA-I/A-II) particles.
Key Words: HDL subpopulations • coronary heart disease • lipids • lipoproteins • apolipoproteins
This article has been cited by other articles:
 |
|
 |
|
  S. Lamon-Fava, D. M. Herrington, D. M. Reboussin, M. Sherman, K. V. Horvath, L. A. Cupples, C. White, S. Demissie, E. J. Schaefer, and B. F. Asztalos Plasma Levels of HDL Subpopulations and Remnant Lipoproteins Predict the Extent of Angiographically-Defined Coronary Artery Disease in Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 575 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Soro-Paavonen, J. Naukkarinen, M. Lee-Rueckert, H. Watanabe, E. Rantala, S. Soderlund, A. Hiukka, P. T. Kovanen, M. Jauhiainen, L. Peltonen, et al. Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL J. Lipid Res., June 1, 2007; 48(6): 1409 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hirayama, T. Miida, O. Miyazaki, and Y. Aizawa Pre{beta}1-HDL Concentration Is a Predictor of Carotid Atherosclerosis in Type 2 Diabetic Patients Diabetes Care, May 1, 2007; 30(5): 1289 - 1291. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Chirinos, J. P. Zambrano, S. Chakko, A. Schob, R. B. Goldberg, G. Perez, and A. J. Mendez Ability of Serum to Decrease Cellular AcylCoA:Cholesterol Acyl Transferase Activity Predicts Cardiovascular Outcomes Circulation, October 18, 2005; 112(16): 2446 - 2453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, M. de la Llera-Moya, G. E. Dallal, K. V. Horvath, E. J. Schaefer, and G. H. Rothblat Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux J. Lipid Res., October 1, 2005; 46(10): 2246 - 2253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Nambi and C. M. Ballantyne Fat, Fit, and Leading the Charge: The Evolution of Measuring High-Density Lipoprotein Subpopulations Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2013 - 2015. [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, D. Collins, L. A. Cupples, S. Demissie, K. V. Horvath, H. E. Bloomfield, S. J. Robins, and E. J. Schaefer Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2185 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Bisoendial, G. K. Hovingh, K. El Harchaoui, J. H.M. Levels, S. Tsimikas, K. Pu, A. E. Zwinderman, J. A. Kuivenhoven, J. J.P. Kastelein, and E. S.G. Stroes Consequences of Cholesteryl Ester Transfer Protein Inhibition in Patients With Familial Hypoalphalipoproteinemia Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): e133 - e134. [Full Text] [PDF]
|
|
|
|
|
|
H. Hajj Hassan, S. Blain, B. Boucher, M. Denis, L. Krimbou, and J. Genest Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release J. Lipid Res., July 1, 2005; 46(7): 1457 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Brousseau, M. R. Diffenderfer, J. S. Millar, C. Nartsupha, B. F. Asztalos, F. K. Welty, M. L. Wolfe, M. Rudling, I. Bjorkhem, B. Angelin, et al. Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1057 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Suzuki, H. Wada, S. Maeda, K. Saito, S. Minatoguchi, K. Saito, and M. Seishima Increased Plasma Lipid-Poor Apolipoprotein A-I in Patients with Coronary Artery Disease Clin. Chem., January 1, 2005; 51(1): 132 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, L. A. Cupples, S. Demissie, K. V. Horvath, C. E. Cox, M. C. Batista, and E. J. Schaefer High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2181 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. Ruel, P. Couture, J. S. Cohn, A. Bensadoun, M. Marcil, and B. Lamarche Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism J. Lipid Res., August 1, 2004; 45(8): 1528 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Freedman, J. D. Otvos, E. J. Jeyarajah, I. Shalaurova, L. A. Cupples, H. Parise, R. B. D'Agostino, P. W.F. Wilson, and E. J. Schaefer Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study Clin. Chem., July 1, 2004; 50(7): 1189 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Olchawa, B. A. Kingwell, A. Hoang, L. Schneider, O. Miyazaki, P. Nestel, and D. Sviridov Physical Fitness and Reverse Cholesterol Transport Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1087 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, K. V. Horvath, K. Kajinami, C. Nartsupha, C. E. Cox, M. Batista, E. J. Schaefer, A. Inazu, and H. Mabuchi Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency J. Lipid Res., March 1, 2004; 45(3): 448 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hattori, T. Kujiraoka, T. Egashira, E. Saito, T. Fujioka, S. Takahashi, M. Ito, J. A. Cooper, I. P. Stepanova, M. N. Nanjee, et al. Association of Coronary Heart Disease with Pre-{beta}-HDL Concentrations in Japanese Men Clin. Chem., March 1, 2004; 50(3): 589 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, M. Batista, K. V. Horvath, C. E. Cox, G. E. Dallal, J. S. Morse, G. B. Brown, and E. J. Schaefer Change in {alpha}1 HDL Concentration Predicts Progression in Coronary Artery Stenosis Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 847 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Miida, O. Miyazaki, Y. Nakamura, S. Hirayama, O. Hanyu, I. Fukamachi, and M. Okada Analytical performance of a sandwich enzyme immunoassay for pre{beta}1-HDL in stabilized plasma J. Lipid Res., March 1, 2003; 44(3): 645 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Asztalos, K. V. Horvath, J. R. McNamara, P. S. Roheim, J. J. Rubinstein, and E. J. Schaefer Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients J. Lipid Res., October 1, 2002; 43(10): 1701 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Sanchez-Muniz, M. C. Merinero, S. Rodriguez-Gil, J. M Ordovas, S. Rodenas, and C. Cuesta Dietary Fat Saturation Affects Apolipoprotein AII Levels and HDL Composition in Postmenopausal Women J. Nutr., January 1, 2002; 132(1): 50 - 54. [Abstract] [Full Text] [PDF]
|
|